Acceder

Publicaciones - INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA

Cargando...
Masiá M, Padilla S, García N, Jarrin I, Bernal E, López N, Hernández I, Gutiérrez F. Endothelial function is impaired in HIV-infected patients with lipodystrophy. Antivir Ther. 2010;15(1):101-10. doi: 10.3851/IMP1491. PubMed PMID: 20167996.
AÑO: 2010; IF: 2.594
20167996
Sparano J.A., Vrdoljak E., Rixe O., Xu B., Manikhas A., Medina C., Da Costa S.C.V., Ro J., Rubio G., Rondinon M., Manga G.P., Peck R., Poulart V., Conte P. Randomized Phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. Journal of Clinical Oncology. 10 July 2010. 28:3256-3263. 10.1200/JCO.2009.24.4244
AÑO: 2010; IF: 18.97
20530276
López-Hernández R, Valdés M, Lucas D, Campillo JA, Martínez-Garcia P, Salama H, López M, Salgado G, Botella C, Minguela A, Miras M, Alvarez-López MR, Carballo F, Muro M. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol. 2010 May;71(5):512-4. doi: 10.1016/j.humimm.2010.02.003. Epub 2010 Mar 4. PubMed PMID: 20152875.
AÑO: 2010; IF: 2.872
20152875
Martínez E, Larrousse M, Podzamczer D, Pérez I, Gutiérrez F, Loncá M, Barragán P, Deulofeu R, Casamitjana R, Mallolas J, Pich J, Gatell JM; BICOMBO Study Team. Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. AIDS. 2010 Jan 28;24(3):F1-9. doi: 10.1097/QAD.0b013e32833562c5. PubMed PMID: 20009917.
AÑO: 2010; IF: 5.003
20009917
Muñiz J, Gómez-Doblas JJ, Santiago-Pérez MI, Lekuona-Goya I, Murga-Eizagaetxebarría N, de Teresa-Galván SS E, Cruz-Fernández JM, Castro-Beiras A; CAM2 Project working group. The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial. Health Qual Life Outcomes. 2010 Nov 22;8:137. doi: 10.1186/1477-7525-8-137. PubMed PMID: 21092191; PubMed Central PMCID: PMC3002321.
AÑO: 2010; IF: 1.86
21092191
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA